Status:
COMPLETED
Correlation Between Visual Field Defects on FORESEE HOME and on Optical Coherence Tomography in Choroidal Neovascularization Subjects
Lead Sponsor:
Notal Vision Ltd.
Conditions:
Age Related Macular Degeneration
Eligibility:
All Genders
50+ years
Brief Summary
The FORESEE HOME is used in the recent years to detect Age-related Macular Degeneration (AMD) lesions. The device is capable of differentiation as to stages of AMD and early detection of changes inclu...
Eligibility Criteria
Inclusion
- Capable and willing to sign a consent form and participate in the study
- Subjects diagnosed with CNV
- Did not perform more then 4 anti- VGEF injections
- VA with habitual correction better then 6/45 in the study eye
- Ability to understand instructions
- Familiar with computer usage
Exclusion
- Evidence of macular disease other than AMD or glaucoma in the study eye
- Presence of any significant media opacity that precludes a clear view of the macular area as identified in the study eye by biomicroscopy,
- Any non-macular related ocular surgery performed within 3 months prior to study entry in the target eye
- Participation in another study with the exclusion of AREDS study
Key Trial Info
Start Date :
June 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2014
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00884637
Start Date
June 1 2009
End Date
March 1 2014
Last Update
October 3 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sorasky Medical Center
Tel Aviv, Israel